Skip to main content

News

Where hypotheses become headlines: Featured coverage of the breakthroughs—and the people—driving our research forward

For media inquiries, email us: [email protected]


Featured News
Tiantian Liu
News

Scripps Research scientist to receive $2.76 million NIAID New Innovators Award

Greg Tabor
News

Paying It Forward: Greg Tabor on Giving Back to the Next Generation

Filter by:
  • Retinal protein-transport discovery may help define new strategies for treating eye disease
    News

    Retinal protein-transport discovery may help define new strategies for treating eye disease

    A new study reveals how proteins from the eye’s nerve cells relay visual cues to different parts of the brain. 

  • FDA accepts IND application for novel immunotherapeutic for prostate cancer in development by Calibr at Scripps Research
    News

    FDA accepts IND application for novel immunotherapeutic for prostate cancer in development by Calibr at Scripps Research

    Calibr announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application for the treatment of metastatic castration-resistant prostate cancer.

  • Discovery of anti-opioid pathway offers new route to designing safer pain medications
    News

    Discovery of anti-opioid pathway offers new route to designing safer pain medications

    The discovery of GPR139 presents a new target for making safer pain medications. Nematodes helped reveal the genetic network that controls opioid activation of a nervous system.

  • Society of Heterocyclic Chemistry honors Dale Boger with E.C. Taylor Senior Award
    News

    Society of Heterocyclic Chemistry honors Dale Boger with E.C. Taylor Senior Award

    Dale Boger, PhD, the Richard and Alice Cramer Professor of Chemistry at Scripps Research, has been awarded the E.C. Taylor Senior Award by the International Society of Heterocyclic Chemistry.

  • Scientists discover ‘forgetting’ enzyme that lops brain cell branches
    News

    Scientists discover ‘forgetting’ enzyme that lops brain cell branches

    The “synapse pruning” process that underlies everyday learning involves a pruning function mediated by an enzyme called caspase 2.

  • Peter Schultz wins Tetrahedron Prize for Creativity in Organic Chemistry
    News

    Peter Schultz wins Tetrahedron Prize for Creativity in Organic Chemistry

    Scripps Research President and Chief Executive Officer Peter Schultz is recognized for his significant original contributions to the field of organic chemistry.

  • A chemical clue to how life started on Earth
    News

    A chemical clue to how life started on Earth

    Every living thing on Earth stems from the same limited set of 20 amino acids, and a new study suggests this didn't happen by accident. 

  • Chemist Kim Janda honored with ACS Portoghese Lectureship Award
    News

    Chemist Kim Janda honored with ACS Portoghese Lectureship Award

    The Medicinal Chemistry Division of ACS, along with the Journal of Medicinal Chemistry, will present Janda with the 2019 Philip S. Portoghese Medicinal Chemistry Lectureship Award to honor his many contributions to medicinal chemistry research.

  • Viral HIV vaccine gives durable protection against tough strains
    News

    Viral HIV vaccine gives durable protection against tough strains

    A nontraditional HIV vaccine from Farzan lab gives durable protection against two hard-to-fight lab strains, including one dubbed “the death star” due to how many vaccine candidates it has killed.

  • Exosomes may hold the answer to treating, diagnosing developmental brain disorders
    News

    Exosomes may hold the answer to treating, diagnosing developmental brain disorders

    A new study shows that these tiny “cargo” transporters are not only integral to the development of neurons and neural circuits, but they can restore health to brain cells affected by developmental disease. 

  • Scripps Research ranked top U.S. nonprofit scientific institute for second consecutive year
    News

    Scripps Research ranked top U.S. nonprofit scientific institute for second consecutive year

    Scripps Research receives the No. 1 U.S. ranking and No. 5 global ranking in the category encompassing nonprofits and nongovernmental organizations (NGOs).

  • Broadly neutralizing antibody prevents lethality from fentanyl class of synthetic opioids
    News

    Broadly neutralizing antibody prevents lethality from fentanyl class of synthetic opioids

    Scripps Research scientists develop a first-ever monoclonal antibody that can mitigate the effects of fentanyl and carfentanil, and overcome shortfalls of existing overdose-treatment options.

  • PTSD study identifies potential target for memory disruption
    News

    PTSD study identifies potential target for memory disruption

    A new study from Scripps Research suggests it may be possible to disarm the emotional memories of trauma that drive PTSD symptoms.

  • Ambassadors from more than 35 countries visit Scripps Research on State Department tour
    News

    Ambassadors from more than 35 countries visit Scripps Research on State Department tour

    More than 35 ambassadors representing countries across four continents toured Scripps Research to learn more about San Diego’s biomedical research sector.

  • Chemist John Yates receives 2019 ASMS John B. Fenn Award for innovations that advanced mass spectrometry
    News

    Chemist John Yates receives 2019 ASMS John B. Fenn Award for innovations that advanced mass spectrometry

    Yates is the lead inventor of the SEQUEST software and algorithm that laid a critical foundation for the field of proteomics and dramatically enhanced mass spectrometry's ability to answer important biological and clinical questions.

  • FDA to consider Scripps Research drug ozanimod for treatment of multiple sclerosis
    News

    FDA to consider Scripps Research drug ozanimod for treatment of multiple sclerosis

    The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application for ozanimod, a potential treatment for multiple sclerosis that was created at Scripps Research.

  • Jeanne Loring named ‘Stem Cell Pioneer of the Year’ in inaugural Xconomy Awards
    News

    Jeanne Loring named ‘Stem Cell Pioneer of the Year’ in inaugural Xconomy Awards

    Loring, a genomics researcher and professor emeritus at Scripps Research, is also founding director of the institute’s Center for Regenerative Medicine.

  • An influenza virus mutation could be the secret to better egg-based seasonal vaccines
    News

    An influenza virus mutation could be the secret to better egg-based seasonal vaccines

    Preparing a seasonal flu vaccine with the G186V mutation may prevent a vexing problem that commonly occurs during the vaccine manufacturing process.

  • New immunotherapy insights: Killer T cells that amplify immune response to viral infections may be a key to better cancer drugs
    News

    New immunotherapy insights: Killer T cells that amplify immune response to viral infections may be a key to better cancer drugs

    Scripps Research scientists discover a mechanism for boosting the body's production of self-renewing T cells, offering a potential new pathway for enhancing cancer immunotherapy.

  • Scripps Research scientists reveal exceptional structural detail of novel protein family involved in sour taste reception and prevalent in digestive and immune systems
    News

    Scripps Research scientists reveal exceptional structural detail of novel protein family involved in sour taste reception and prevalent in digestive and immune systems

    Using cryogenic electron microscopy, researchers gained crucial structural and functional insights into proton channels involved in balance, taste and yet-unidentified roles in human health.

  • Prescription drug costs steadily soar, yet price transparency is lacking
    News

    Prescription drug costs steadily soar, yet price transparency is lacking

    Scripps Research analyzed pharmacy insurance claims from over 35 million Americans, finding ‘continual, marked, annual increases’ of popular brand-name drugs.

  • Discovery of bacteria’s protein quality control agent offers insight into origins of life
    News

    Discovery of bacteria’s protein quality control agent offers insight into origins of life

    Soon after cells invented protein assembly, they faced another task crucial to survival: Disposing of incomplete protein fragments. Claudio Joazeiro, PhD, uncovers how bacteria and archaea handle recycling.

  • Calibr names drug development veteran Pamela Garzone as chief medical officer
    News

    Calibr names drug development veteran Pamela Garzone as chief medical officer

    Garzone, an industry leader in translational research and clinical development, fills a critical leadership role as several of Calibr’s portfolio programs advance toward the clinic.

  • Monkey-infecting virus may provide part of future HIV vaccine
    News

    Monkey-infecting virus may provide part of future HIV vaccine

    A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has shown promise as a potential component of a vaccine against HIV. 

Groundbreaking Science.
Life-changing Medicine.